New diabetes clinical trial: A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years
- Get link
- X
- Other Apps
Published on: August 28, 2020 at 09:30PM
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Empagliflozin; Drug: Placebo
Sponsor: Boehringer Ingelheim
Not yet recruiting
https://ift.tt/32sZ0uA
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Empagliflozin; Drug: Placebo
Sponsor: Boehringer Ingelheim
Not yet recruiting
https://ift.tt/32sZ0uA
Comments
Post a Comment